Highlights and Quick Summary
- Common Equity (Total) for the quarter ending September 30, 2022 was $96.3 Million (a -16.45% decrease compared to previous quarter)
- Year-over-year quarterly Common Equity (Total) decreased by -37.87%
- Annual Common Equity (Total) for 2021 was $155 Million (a -35.99% decrease from previous year)
- Annual Common Equity (Total) for 2020 was $242 Million (a 29.48% increase from previous year)
- Annual Common Equity (Total) for 2019 was $187 Million (a -300.95% decrease from previous year)
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Common Equity (Total) of Atreca, Inc.
Most recent Common Equity (Total)of BCEL including historical data for past 10 years.Interactive Chart of Common Equity (Total) of Atreca, Inc.
Atreca, Inc. Common Equity (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $96.25 | $115.2 | $137.78 | – |
| 2021 | $154.93 | $175.43 | $198.6 | $221.4 | $154.93 |
| 2020 | $242.06 | $261.28 | $154.12 | $170.14 | $242.06 |
| 2019 | – | $186.95 | $205.0 | $218.88 | $186.95 |
| 2018 | – | – | – | $-93.03 | $-93.03 |
| 2017 | – | – | – | – | $-56.57 |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology